Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomography

Journal of Biomedical Optics

Volumn 19, Issue 3, 2014, Pages

  Yi, Ji ^a   Radosevich, Andrew J ^a   Stypula Cyrus, Yolanda ^a   Mutyal, Nikhil N ^a   Azarin, Samira Michelle ^a   Horcher, Elizabeth ^a   Goldberg, Michael J ^c   Bianchi, Laura K ^c   Bajaj, Shailesh ^c   Roy, Hemant K ^b   Backman, Vadim ^a  

^a Northwestern University   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Colorectal; Field carcinogenesis; Optical properties; Pancreatic; Ultrastructural

Indexed keywords

BIOPSY; DISEASES; OPTICAL PROPERTIES;

CANCER PROGRESSION; COLORECTAL; COLORECTAL CANCERS (CRC); FIELD CARCINOGENESIS; PANCREATIC; SPATIALLY RESOLVED; SPECTROSCOPIC OPTICAL COHERENCE TOMOGRAPHIES; ULTRASTRUCTURAL;

PATHOLOGY;

ARTICLE; COLORECTAL TUMOR; HUMAN; IMAGE PROCESSING; METHODOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PANCREAS TUMOR; PATHOLOGY; ULTRASTRUCTURE;

COLORECTAL NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PANCREATIC NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84897011741     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.3.036013     Document Type: Article

References (87)

1. H. Chai and R. E. Brown, "Field effect in cancer-an update," Ann. Clin. Lab. Sci. 39(4), 331-337 (2009).
2. D. P. Slaughter, H. W. Southwick, and W. Smejkal, "Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin," Cancer 6(5), 963-968 (1953).
3. W. A. Franklin et al., "Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis," J. Clin. Invest. 100(8), 2133-2137 (1997).
4. L. Shen et al., "MGMT promoter methylation and field defect in sporadic colorectal cancer," J. Natl. Cancer Inst. 97(18), 1330-1338 (2005).
5. H. Suzuki et al., "Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer," Nat. Genet. 36(4), 417-422 (2004).
6. J. Mehrotra et al., "Quantitative, spatial resolution of the epigenetic field effect in prostate cancer," Prostate 68(2), 152-160 (2008).
7. L. Nonn, V. Ananthanarayanan, and P. H. Gann, "Evidence for field cancerization of the prostate," Prostate 69(13), 1470-1479 (2009).
8. L. J. Prevo et al., "p53-mutant clones and field effects in Barrett's esophagus," Cancer Res. 59(19), 4784-4787 (1999).
9. G. Dakubo et al., "Clinical implications and utility of field cancerization," Cancer Cell Int. 7(1), 1-12 (2007).
10. B. J. M. Braakhuis et al., "A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications," Cancer Res. 63(8), 1727-1730 (2003).
11. M. Endoh et al., "RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer," Br. J. Cancer 93(12), 1395-1399 (2005).
12. P. S. Yan et al., "Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue," Clin. Cancer Res. 12(22), 6626-6636 (2006).
13. U. Utzinger et al., "Near-infrared Raman spectroscopy for in vivo detection of cervical precancers," Appl. Spectrosc. 55(8), 955-959 (2001).
14. M. D. Keller et al., "Detecting temporal and spatial effects of epithelial cancers with Raman spectroscopy," Dis. Markers 25(6), 323-337 (2008).
15. D. S. Alberts et al., "Karyometry of the colonic mucosa," Cancer Epidemiol. Biomarkers Prev. 16(12), 2704-2716 (2007).
16. F. E. Robles et al., "Detection of early colorectal cancer development in the azoxymethane rat carcinogenesis model with Fourier domain low coherence interferometry," Biomed. Opt. Express 1(2), 736-745 (2010).
17. A. Sharwani et al., "Assessment of oral premalignancy using elastic scattering spectroscopy," Oral Oncol. 42(4), 343-349 (2006).
18. H. K. Roy et al., "Association between rectal optical signatures and colonic neoplasia: potential applications for screening," Cancer Res. 69(10), 4476-4483 (2009).
19. V. Turzhitsky et al., "Investigating population risk factors of pancreatic cancer by evaluation of optical markers in the duodenal mucosa," Dis. Markers 25(6), 313-321 (2008).
20. A. J. R. N. N. Mutyal et al., "In-vivo risk stratification of colon carcinogenesis by measurement of optical properties with novel lensfree fiber optic probe using low-coherence enhanced backscattering spectroscopy (LEBS)," presented at Conf. 8230: Biomedical Applications of Light Scattering VI, SPIE Photonics West, San Fransicso, CA (2012).
21. N. N. Mutyal et al., "In-vivo risk stratification of pancreatic cancer by evaluating optical properties in duodenal mucosa," in Biomedical Optics and 3-D Imaging, OSATechnical Digest, p. BSu5A. 10, Optical Society of America, Miami, Florida (2012).
22. A. J. Radosevich et al., "Ultrastructural alterations in field carcinogenesis measured by enhanced backscattering spectroscopy," J. Biomed. Opt. 18(9), 097002 (2013).
23. J. Yi et al., "Can OCT be sensitive to nanoscale structural alterations in biological tissue?" Opt. Express 21(7), 9043-9059 (2013).
24. J. Yi and V. Backman, "Imaging a full set of optical scattering properties of biological tissue by inverse spectroscopic optical coherence tomography," Opt. Lett. 37(21), 4443-4445 (2012).
25. J. Yi et al., "Inverse spectroscopic optical coherence tomography (ISOCT): non-invasively quantifying the complete optical scattering properties from week scattering tissue," in Biomedical Optics and 3-D Imaging, OSA Technical Digest, p. BTu3A. 88, Optical Society of America, Miami, Florida (2012).
26. S. Bajaj et al., "915 development of novel optical technologies for early colon carcinogenesis detection via nanoscale mass density fluctuations: potential implications for endoscopic diagnostics," Gastrointest. Endosc. 75(4), AB172 (2012).
27. D. Huang et al., "Optical coherence tomography," Science 254(5035), 1178-1181 (1991).
28. A. F. Fercher et al., "Optical coherence tomography-principles and applications," Rep. Prog. Phys. 66(2), 239-303 (2003).
29. D. Levitz et al., "Determination of optical scattering properties of highly-scattering media in optical coherence tomography images," Opt. Express 12(2), 249-259 (2004).
30. J. M. Schmitt, A. Knüttel, and R. F. Bonner, "Measurement of optical properties of biological tissues by low-coherence reflectometry," Appl. Opt. 32(30), 6032-6042 (1993).
31. F. J. van der Meer et al., "Localized measurement of optical attenuation coefficients of atherosclerotic plaque constituents by quantitative optical coherence tomography," IEEE Trans. Med. Imaging 24(10), 1369-1376 (2005).
32. A. I. Kholodnykh et al., "Precision of measurement of tissue optical properties with optical coherence tomography," Appl. Opt. 42(16), 3027-3037 (2003).
33. N. Bosschaart et al., "Measurements of wavelength dependent scattering and backscattering coefficients by low-coherence spectroscopy," J. Biomed. Opt. 16(3), 030503 (2011).
34. C. Xu et al., "Characterization of atherosclerosis plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography," J. Biomed. Opt. 13(3), 034003 (2008).
35. V. M. Kodach et al., "Determination of the scattering anisotropy with optical coherence tomography," Opt. Express 19(7), 6131-6140 (2011).
36. F. E. Robles, S. Chowdhury, and A. Wax, "Assessing hemoglobin concentration using spectroscopic optical coherence tomography for feasibility of tissue diagnostics," Biomed. Opt. Express 1(1), 310-317 (2010).
37. N. Bosschaart et al., "Quantitative measurements of absorption spectra in scattering media by low-coherence spectroscopy," Opt. Lett. 34(23), 3746-3748 (2009).
38. A. J. Radosevich et al., "Structural length-scale sensitivities of reflectance measurements in continuous random media under the Born approximation," Opt. Lett. 37(24), 5220-5222 (2012).
39. T. McGarrity and L. Peiffer, "Protein kinase C activity as a potential marker for colorectal neoplasia," Digest Dis. Sci. 39(3), 458-463 (1994).
40. T. J. McGarrity et al., "Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas," Cancer 66(7), 1539-1543 (1990).
41. I. Vucenik et al., "Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy," Anticancer Res. 21(2B), 1247-1255 (2001).
42. C. M. Payne et al., "Crypt-restricted loss and decreased protein expression of cytochrome c oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk," Cancer Epidemiol. Biomarkers Prev. 14(9), 2066-2075 (2005).
43. M. Anti et al., "Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence," Gut 34(4), 525-530 (1993).
44. C. Bernstein et al., "A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies," Cancer Res. 59(10), 2353-2357 (1999).
45. L.-C. Chen et al., "Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients," Cancer Res. 64(10), 3694-3700 (2004).
46. C.-Y. Hao et al., "Altered gene expression in normal colonic mucosa of individuals with polyps of the colon," Dis. Colon Rectum 48(12), 2329-2335 (2005).
47. H. Cui et al., "Loss of IGF2 imprinting: a potential marker of colorectal cancer risk," Science 299(5613), 1753-1755 (2003).
48. C. R. Daniel et al., "TGF-? expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma," Cancer Epidemiol. Biomarkers Prev. 18(1), 65-73 (2009).
49. T. Keku et al., "Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas," BMC Cancer 8(1), 143-151 (2008).
50. A. C. J. Polley et al., "Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia," Cancer Res. 66(13), 6553-6562 (2006).
51. A. J. Gomes et al., "Rectal mucosal microvascular blood supply increase is associated with colonic neoplasia," Clin. Cancer Res. 15(9), 3110-3117 (2009).
52. H. K. Roy et al., "Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk," Gastroenterology 135(4), 1069-1078 (2008).
53. H. K. Roy et al., "Optical measurement of rectal microvasculature as an adjunct to flexible sigmoidosocopy: gender-specific implications," Cancer Prev. Res. 3(7), 844-851 (2010).
54. A. Albini, D. M. Noonan, and N. Ferrari, "Molecular pathways for cancer angioprevention," Clin. Cancer Res. 13(15), 4320-4325 (2007).
55. R. Z. Chen et al., "DNA hypomethylation leads to elevated mutation rates," Nature 395(6697), 89-93 (1998).
56. S. B. Baylin, "DNA methylation and gene silencing in cancer," Nat. Clin. Pract. Oncol. 2(Suppl 1), S4-S11 (2005).
57. Y. Stypula-Cyrus et al., "HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure," PLoS One 8(5), e64600 (2013).
58. Y. E. Stypula et al., "472 histone deacetylase (HDAC) expression as a biomarker for colorectal cancer (CRC) field carcinogenesis: role in high order chromatin modulation," Gastroenterology 144(5), S-85 (2013).
59. A. Razin, "CpG methylation, chromatin structure and gene silencing-a three-way connection," EMBO J. 17(17), 4905-4908 (1998).
60. F. Fuks, "DNA methylation and histone modifications: teaming up to silence genes," Curr. Opin. Genet. Dev. 15(5), 490-495 (2005).
61. N. A. Bhowmick, E. G. Neilson, and H. L. Moses, "Stromal fibroblasts in cancer initiation and progression," Nature 432(7015), 332-337 (2004).
62. L. Ge et al., "Could stroma contribute to field cancerization?" Med. Hypotheses 75(1), 26-31 (2010).
63. T. L. Ratliff, "TGF-? signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia," Science 303(5659), 848-851 (2004).
64. J. M. Schmitt and G. Kumar, "Optical scattering properties of soft tissue: a discrete particle model," Appl. Opt. 37(13), 2788-2797 (1998).
65. C. Amoozegar et al., "Experimental verification of T-matrix-based inverse light scattering analysis for assessing structure of spheroids as models of cell nuclei," Appl. Opt. 48(10), D20-D25 (2009).
66. J. D. Rogers, ?. R. Çapo?lu, and V. Backman, "Nonscalar elastic light scattering from continuous random media in the Born approximation," Opt. Lett. 34(12), 1891-1893 (2009).
67. J. Schmitt and G. Kumar, "Turbulent nature of refractive-index variations in biological tissue," Opt. Lett. 21(16), 1310-1312 (1996).
68. C. J. R. Sheppard, "Fractal model of light scattering in biological tissue and cells," Opt. Lett. 32(2), 142-144 (2007).
69. M. Xu and R. R. Alfano, "Fractal mechanisms of light scattering in biological tissue and cells," Opt. Lett. 30(22), 3051-3053 (2005).
70. J. D. Rogers et al., "Modeling light scattering in tissue as continuous random media using a versatile refractive index correlation function," IEEE J. Sel. Top. Quantum Electron. 20(2), 1-14 (2014).
71. H. G. Davies et al., "The use of the interference microscope to determine dry mass in living cells and as a quantitative cytochemical method," Q. J. Microsc. Sci. s3-95(31), 271-304 (1954).
72. R. Barer and S. Tkaczyk, "Refractive index of concentrated protein solutions" Nature 173, 821-822 (1954).
73. ?. R. Çapo?lu et al., "Accuracy of the Born approximation in calculating the scattering coefficient of biological continuous random media," Opt. Lett. 34(17), 2679-2681 (2009).
74. G. Zonios et al., "Diffuse reflectance spectroscopy of human adenomatous colon polyps in vivo," Appl. Opt. 38(31), 6628-6637 (1999).
75. R. Doornbos et al., "The determination of in vivo human tissue optical properties and absolute chromophore concentrations using spatially resolved steady-state diffuse reflectance spectroscopy," Phys. Med. Biol. 44(4), 967-981 (1999).
76. M. Huzaira et al., "Topographic variations in normal skin, as viewed by in vivo reflectance confocal microscopy," J. Invest. Dermatol. 116(6), 846-852 (2001).
77. R. Leitgeb et al., "Spectral measurement of absorption by spectroscopic frequency-domain optical coherence tomography," Opt. Lett. 25(11), 820-822 (2000).
78. F. E. Robles and A. Wax, "Measuring morphological features using light-scattering spectroscopy and Fourier-domain low-coherence interferometry," Opt. Lett. 35(3), 360-362 (2010).
79. N. Otsu, "A threshold selection method from gray-level histograms," IEEE Trans. Syst. Man Cybern. 9(1), 62-66 (1979).
80. D. P. Kunte et al., "Down-regulation of the tumor suppressor gene C-terminal Src kinase: An early event during premalignant colonic epithelial hyperproliferation," FEBS Lett. 579(17), 3497-3502 (2005).
81. O. H. Kramer et al., "The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2," EMBO J. 22(13), 3411-3420 (2003).
82. A. M. Baker et al., "Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK," Oncogene 32(14), 1863-1868 (2012).
83. H. Matsubayashi et al., "Age-and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice," Clin. Cancer Res. 11(2), 573-583 (2005).
84. H. Matsubayashi et al., "DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease," Cancer Res. 66(2), 1208-1217 (2006).
85. A. J. Bannister and T. Kouzarides, "Regulation of chromatin by histone modifications," Cell Res. 21(3), 381-395 (2011).
86. E. W. Y. Tung and L. M. Winn, "Epigenetic modifications in valproic acid-induced teratogenesis," Toxicol. Appl. Pharmacol. 248(3), 201-209 (2010).
87. H. Roy et al., "Spectral slope from the endoscopically-normal mucosa predicts concurrent colonic neoplasia: a pilot ex-vivo clinical study," Dis. Colon Rectum 51(9), 1381-1386 (2008).